8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
People assigned to a diet, food or program and measured.
2015 / Phase I-II clinical trial
A phase I-II trial examined high-dose intravenous vitamin C added to chemotherapy in 14 patients with advanced cancer and limited treatment response expectations. The infusions were generally well tolerated, with only transient adverse events recorded. Pharmacokinetic analyses indicated higher tissue uptake of vitamin C following chemotherapy without increases in urinary oxalic acid. Three patients exhibited brief periods of stable disease and functional improvement.
Hoffer LJ, Robitaille L, Zakarian R, et al. PLoS One, 2015. PMID 25848948
2015 / Randomized controlled trial
An 8-week randomized double-blind placebo-controlled trial evaluated 43 adult patients with major depressive disorder receiving citalopram with either vitamin C (n=21) or placebo (n=22). Although depression scores declined in both arms, the difference between groups was not statistically significant (P = .5). Remission rates, response rates, and adverse effects showed no significant differences between the vitamin C and placebo groups.
Sahraian A, Ghanizadeh A, Kazemeini F Trials, 2015. PMID 25873303
2015 / Intervention trials (long-term VitDmet and short-term VitDbol bolus)
Researchers analyzed peripheral blood mononuclear cells from a 5-month vitamin D3 intervention study (VitDmet) and a separate short-term, high-dose vitamin D3 bolus trial (VitDbol). In the VitDmet study, changes in the mRNA expression of 12 selected VDR target genes significantly correlated with changes in serum 25-hydroxyvitamin D3 levels. Relevance calculations identified serum parathyroid hormone and genes including STS, BCL6, ITGAM, LRRC25, LPGAT1, TREM1, DUSP10, and CD14 as key parameters that segregated participants into high and low responders. In the VitDbol trial, direct transcriptional effects were observed, including an up to 2.1-fold increase in target gene expression one day after supplementation onset.
Vukić M, Neme A, Seuter S, et al. PLoS One, 2015. PMID 25875760
2015 / Randomized controlled trial
This randomized controlled trial evaluated the effect of a single pre-breakfast dose of thylakoid-rich spinach extract versus placebo in overweight women. Compared to placebo, thylakoids reduced hunger by 21% (p < 0.05), increased satiety by 14% (p < 0.01), and decreased cravings for all snacks and sweets by 36% (p < 0.05), salty snacks by 30% (p < 0.01), sweet snacks by 38% (p < 0.001), and sweet-and-fat snacks by 36% (p < 0.05). Subjective liking for sweets decreased by 28% (p < 0.01), and reductions in wanting snacks were positively correlated with higher emotional eating scores (p < 0.01). Although wanting and liking scores correlated with reduced intake (p < 0.01), overall food intake was not significantly affected.
Stenblom EL, Egecioglu E, Landin-Olsson M, et al. Appetite, 2015. PMID 25895695
2015 / Randomized crossover trial
Nine healthy young men completed four 2-week interventions (normocaloric bedrest, normocaloric ambulatory, hypocaloric bedrest, hypocaloric ambulatory) separated by 5 months to examine the effects of a 25% caloric restriction and 6° head-down bedrest. Caloric restriction showed a strong trend toward reduced basal muscle sympathetic nerve activity (22±3 vs. 14±4 burst/min, p = 0.06). Both bedrest and caloric restriction were associated with lower systolic blood pressure during lower body negative pressure (p < 0.01), but heart rate increased with bedrest and decreased with caloric restriction. Survival analysis demonstrated a significant reduction in orthostatic tolerance following caloric restriction (normocaloric finishers: 12/16; hypocaloric finishers: 6/16; p = 0.03).
Florian JP, Baisch FJ, Heer M, et al. PLoS One, 2015. PMID 25915488
2015 / Interventional study
An 8-week alternate day fasting (ADF) protocol was tested in 59 obese subjects, with food provided on fast days. Body weight decreased by 4.2 ± 0.3% (P < 0.0001). Adverse events reported included constipation (17%), water retention (2%), dizziness (<20%), general weakness (<15%), and non-significantly increased bad breath (14% to 29%). Depression and binge eating decreased (P < 0.01), restrictive eating increased (P < 0.01), body image improved (P < 0.01), and purgative behavior and fear of fatness were unchanged.
Hoddy KK, Kroeger CM, Trepanowski JF, et al. Nutr J, 2015. PMID 25943396
2015 / Crossover trial
Subjects completed exercise testing after following a low-PRAL (alkaline-promoting) diet and a high-PRAL diet for 4-9 days each, until target fasted morning urine pH was reached. Maximal exercise respiratory exchange ratio (RER) was significantly lower after the low-PRAL diet compared to the high-PRAL diet (1.10 ± 0.02 vs. 1.20 ± 0.05, p = 0.037). The low-PRAL diet also produced a 21% greater time to exhaustion during anaerobic running (2.56 ± 0.36 vs. 2.11 ± 0.31 sec, p = 0.044) and a trend toward lower RER during submaximal exercise at 70% VO2max (0.88 ± 0.02 vs. 0.96 ± 0.04, p = 0.060).
Caciano SL, Inman CL, Gockel-Blessing EE, et al. J Sports Sci Med, 2015. PMID 25983586
2015 / Randomized crossover trial
In a randomized crossover trial, 24 fasted runners consumed flavored water alone or water with 7 kcal kg-1 chia seed oil before running to exhaustion at ~70% VO2max. Ingesting chia seed oil was accompanied by elevations in plasma alpha-linolenic acid (337% vs 35% with water, 70.8 ± 8.6 vs 20.3 ± 1.8 μg mL-1, p < 0.001). However, run time to exhaustion did not differ between the chia seed oil and water trials (1.86 ± 0.10 vs 1.91 ± 0.13 h, p = 0.577), and no trial differences were found for respiratory exchange ratio, oxygen consumption, ventilation, ratings of perceived exertion, plasma glucose, blood lactate, cortisol, or inflammatory cytokines.
Nieman DC, Gillitt ND, Meaney MP, et al. Nutrients, 2015. PMID 25988762
2015 / Randomized crossover trial
Thirty-five lean men and women participated in a randomized cross-over trial comparing an extended overnight fast to a carbohydrate-rich breakfast (1963 [SD 238] kJ relative to resting metabolic rate) followed by an ad libitum lunch 3 hours later. Lunch intake was higher following extended fasting (by 640 [SD 1042] kJ, P < 0.01), but total intake remained lower than in the breakfast trial (3887 [SD 1326] vs 5213 [SD 1590] kJ, P < 0.001). Afternoon concentrations of peptide tyrosine-tyrosine and leptin were higher after breakfast (both P < 0.05), while insulin was higher after morning fasting (P < 0.01). Acylated and total ghrelin were not suppressed by lunch in the breakfast trial and remained higher than in the fasting trial throughout the afternoon (all P < 0.05), with no differences between trials in afternoon subjective appetite.
Chowdhury EA, Richardson JD, Tsintzas K, et al. Br J Nutr, 2015. PMID 26004166
2015 / Intervention trial with periodic fecal sampling
Researchers evaluated fecal menaquinone profiles, gut microbiota structure, and cardiometabolic biomarkers in 77 overweight Chinese adults consuming a prescribed diet designed to alter gut microbiota composition. Covariance among fecal menaquinones identified two distinct groups ('menaquinotypes'), characterized by differences in MK5, MK9-MK13, and relative abundance of species mostly within Prevotella and Bacteroides. During the intervention, fecal MK4, MK6, and MK8 decreased (P < 0.05), and longitudinal shifts in >100 operational taxonomic units related to altered individual menaquinones. However, neither individual menaquinones nor menaquinotypes were longitudinally associated with markers of glycemia, insulin resistance, or inflammation.
Karl JP, Fu X, Wang X, et al. Am J Clin Nutr, 2015. PMID 26016865
2015 / Randomized controlled trial
A randomized, double-blind, placebo-controlled trial evaluated vitamin B12 ointment against placebo over 2 days in 42 primary care patients experiencing mouth ulcers. Visual analog scale scores for pain were assessed prior to and following treatment. After 2 days, pain scores were significantly lower in the vitamin B12 group than in the control group (mean 0.36 [95% CI, 0.01-0.71] vs. 1.80 [95% CI, 1.16-2.44]; p < 0.001).
Liu HL, Chiu SC Pain Manag Nurs, 2015. PMID 26025792
2015 / Double-blind randomized crossover trial
Sixty overweight and obese individuals consumed a single 5 g dose of thylakoid-rich spinach extract or placebo along with a standard lunch in a double-blind randomized crossover study. Compared to placebo, the spinach extract reduced hunger (p < 0.01) and longing for food over 2 hours (p < 0.01) and increased postprandial plasma glucose concentrations (p < 0.01). No differences were found in plasma lipids or overall energy intake at a subsequent ad libitum dinner, though males showed a trend toward reduced energy intake (p = 0.08).
Rebello CJ, Chu J, Beyl R, et al. J Am Coll Nutr, 2015. PMID 26029978
2015 / Randomized crossover trial
A randomized crossover trial evaluated adding 85 grams of almonds daily to an NCEP Step 1 diet for 6 weeks in 45 patients with coronary artery disease. Almond supplementation raised plasma α-tocopherol by 5.8% (P ≤ 0.05) and improved intakes of fiber, calcium, magnesium, and choline. However, it did not significantly alter vascular function, blood pressure, lipids, or inflammatory markers such as C-reactive protein or tumor necrosis factor-α.
Chen CY, Holbrook M, Duess MA, et al. Nutr J, 2015. PMID 26080804
2015 / Randomized controlled trial
In a 6-month trial, 47 overweight and obese adults without diabetes were randomized to drink 1 liter daily of sucrose-sweetened soft drinks, isocaloric milk, diet cola, or water. Circulating uric acid increased by roughly 15% (P = 0.02) in the sucrose-sweetened soft drink group, with no alterations observed in other groups. Changes in uric acid correlated with shifts in liver fat (P = 0.005), triglycerides (P = 0.02), and insulin (P = 0.002).
Bruun JM, Maersk M, Belza A, et al. Eur J Clin Nutr, 2015. PMID 26081486
2015 / Intervention study with metatranscriptomic and in vitro analyses
Researchers analyzed the skin microbiota transcriptome in acne patients and healthy individuals, and evaluated the effects of vitamin B12 supplementation in 10 healthy subjects. Vitamin B12 biosynthesis genes in Propionibacterium acnes were significantly down-regulated in acne patients compared to healthy individuals. Supplementation of healthy subjects repressed P. acnes vitamin B12 biosynthesis genes and altered the skin microbiota transcriptome, and 1 of the 10 subjects developed acne 1 week after supplementation. In P. acnes cultures, vitamin B12 supplementation promoted porphyrin production.
Kang D, Shi B, Erfe MC, et al. Sci Transl Med, 2015. PMID 26109103
2015 / Double-blind randomised placebo-controlled study
Twenty-seven Crohn's disease patients in remission were assigned to 2000 IU/day vitamin D or placebo for 3 months. At 3 months, 25(OH)D levels were significantly higher in the treated group (p < 0.001), with increased LL-37 concentrations (p = 0.050) and maintenance of intestinal permeability, whereas placebo patients experienced increases in small bowel (p = 0.018) and gastro-duodenal permeability (p = 0.030). Patients reaching 25(OH)D ≥ 75 nmol/L at 3 months had significantly lower CRP (p = 0.019), higher Quality of Life (p = 0.037), and higher LL-37 concentrations (p < 0.001) compared to those with levels < 75 nmol/L.
Raftery T, Martineau AR, Greiller CL, et al. United European Gastroenterol J, 2015. PMID 26137304
2015 / Randomized crossover trial
Twelve pre-menopausal women completed two randomized trials where they consumed an isoenergetic 65 kcal snack of either mixed berries or confectionary sweets around 5 pm, followed 60 minutes later by an ad libitum pasta meal. Energy intake was significantly lower following the berry snack (691 ± 146 kcal) compared to the confectionary snack (824 ± 172 kcal, P < 0.001), while water intake did not differ. No significant differences between trials were found for subjective appetite ratings. Time taken to eat the snack was significantly longer for berries (4.05 ± 1.12 min) than sweets (0.93 ± 0.33 min, P < 0.001).
James LJ, Funnell MP, Milner S Appetite, 2015. PMID 26162950
2015 / Interventional study
In summer 2014, 20 participants from Kaiser Permanente California facilities eliminated all added sugars and artificial sweeteners for 2 weeks. Following the intervention, 95% found sweet foods and drinks tasted sweeter or too sweet, 75% found other foods tasted sweeter, and 95% reported they would use less or no sugar moving forward. In addition, 86.6% of participants stopped craving sugar after 6 days.
Bartolotto C Perm J, 2015. PMID 26176574
2015 / Randomized crossover trial
Fourteen overweight postmenopausal women consumed three 2-week isocaloric diets containing high-fat cheese, high-fat meat, or high carbohydrates in a randomized crossover design. Compared to the carbohydrate diet, the cheese diet increased HDL cholesterol by 5% (P = 0.012) and the meat diet increased it by 8% (P < 0.001). Total cholesterol, LDL cholesterol, and triglycerides did not differ, whereas both cheese and meat diets increased fecal fat and bile acid excretion.
NANO counterpoint →
Thorning TK, Raziani F, Bendsen NT, et al. Am J Clin Nutr, 2015. PMID 26178720
2015 / Pre-post intervention study
Twenty non-obese young men consumed a 3-day high-carbohydrate diet (≥75% of total calories) with body composition assessed by DXA before and after the intervention. Mean carbohydrate intake over the 3 days was 83.7 ± 8.4%. Total body weight, BMI, and both total and appendicular lean body mass significantly increased (p < 0.01), with a strong tendency toward lower body fat percentage (p = 0.05) and no significant change in central lean body mass.
Rouillier MA, David-Riel S, Brazeau AS, et al. Ann Nutr Metab, 2015. PMID 26183608
2015 / Randomized controlled trial
Eighty-one university students were randomized to drink either a carotenoid-rich fruit smoothie or mineral water daily for six weeks. After four weeks, the smoothie group demonstrated a substantial increase in skin yellowness (p<0.001) and a slight rise in skin redness (p<0.001). These skin tone changes persisted at a two-week follow-up and were consistent with carotenoid deposition in the skin.
Tan KW, Graf BA, Mitra SR, et al. PLoS One, 2015. PMID 26186449
2015 / Randomized crossover trial
In a randomized crossover study of 20 healthy adults aged 20 to 35 years, consuming an identical test meal at 08:00 hours produced significantly higher post-meal resting metabolic rate than at 20:00 hours (1,916 kcal, 95% CI: 1,792 to 2,041 vs 1,756 kcal, 95% CI: 1,648 to 1,863; p < 0.001). The morning meal also resulted in significantly lower area-under-the-curve differences for glucose, log-insulin, and free fatty acids compared with the evening meal.
Bo S, Fadda M, Castiglione A, et al. Int J Obes (Lond), 2015. PMID 26219416
2015 / Randomized crossover trial
In a randomized crossover trial, 12 adults with metabolic syndrome consumed three test meals matched for fiber or antioxidant capacity on three occasions with five hours of postprandial monitoring. Insulin was lower after the black bean meal versus the matched meals (p < 0.0001). Plasma antioxidant capacity differed over time (p = 0.002), oxidized LDL showed no difference by meal, and triglycerides and interleukin-6 rose after meals (p < 0.0001).
Reverri EJ, Randolph JM, Steinberg FM, et al. Nutrients, 2015. PMID 26225995
2015 / Randomized crossover trial
Twenty middle-aged participants consumed either a barley kernel-based bread (BB) or a reference white wheat bread for 3 consecutive days in a randomized crossover design, followed by a standardized breakfast on day 4. Compared to reference bread, 3 days of BB increased fasting plasma GLP-1 by 56%, postprandial plasma GLP-2 by 13%, and postprandial plasma PYY by 18%. BB intervention also increased breath H2 excretion by 363% and fasting serum SCFAs by 18%, while decreasing blood glucose responses by 22% and serum insulin responses by 17%. Insulin sensitivity index (ISIcomposite) was improved by 25% following the BB intervention.
Nilsson AC, Johansson-Boll EV, Björck IM Br J Nutr, 2015. PMID 26259632